In Brief: CIS bio international
This article was originally published in The Gray Sheet
Executive Summary
CIS bio international: French in vitro diagnostics firm expects to launch its Kryptor automated immunoanalyzer with Trace technology in Europe by the end of the calendar year. Trace technology provides "homogeneous immunoanalysis," CIS explains, allowing reactions to be measured directly in solution, thus eliminating the "solid reaction phase or washing" required for standard immunoassays. The 300-well microtiter system initially will be sold with a panel of eight tumor markers, free beta hCG, and AFP. Assays slated to be added in 1997 include: prolactin, LH, FSH, hCG and CYFRA 21-1, estradiol, ferritin, beta-2 microglobulin, testosterone, progesterone, and osteocalin. Cardiac and thyroid tests also are under development...